Virtual Press Office and PR Newswire: General Trade show news https://tradeshownews.vporoom.com/ ACON OPTICS (TWSE: 6820) Strengthens AI High-Speed Interconnect Portfolio with CPO and 1.6T Connectivity Technologies at COMPUTEX 2026 https://tradeshownews.vporoom.com/2026-06-15-ACON-OPTICS-TWSE-6820-Strengthens-AI-High-Speed-Interconnect-Portfolio-with-CPO-and-1-6T-Connectivity-Technologies-at-COMPUTEX-2026 Mon, 15 Jun 2026 20:30:00 -0400 https://tradeshownews.vporoom.com/2026-06-15-ACON-OPTICS-TWSE-6820-Strengthens-AI-High-Speed-Interconnect-Portfolio-with-CPO-and-1-6T-Connectivity-Technologies-at-COMPUTEX-2026 PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING https://tradeshownews.vporoom.com/2026-06-15-PLEOPHARMA-TO-PRESENT-NEWDATA-ON-CANNABIS-WITHDRAWAL-In-PATIENTS-WITH-CANNABIS-USE-DISORDER-AND-PHASE-2-PP-01-RESULTS-AT-THE-COLLEGE-ON-PROBLEMS-OF-DRUG-DEPENDENCE-88TH-ANNUAL-SCIENTIFIC-MEETING Mon, 15 Jun 2026 20:07:00 -0400 https://tradeshownews.vporoom.com/2026-06-15-PLEOPHARMA-TO-PRESENT-NEWDATA-ON-CANNABIS-WITHDRAWAL-In-PATIENTS-WITH-CANNABIS-USE-DISORDER-AND-PHASE-2-PP-01-RESULTS-AT-THE-COLLEGE-ON-PROBLEMS-OF-DRUG-DEPENDENCE-88TH-ANNUAL-SCIENTIFIC-MEETING RefrigiWear® Unveils New Heated PPE System at ASSP Safety26 Expo https://tradeshownews.vporoom.com/2026-06-15-RefrigiWear-R-Unveils-New-Heated-PPE-System-at-ASSP-Safety26-Expo Mon, 15 Jun 2026 17:20:00 -0400 https://tradeshownews.vporoom.com/2026-06-15-RefrigiWear-R-Unveils-New-Heated-PPE-System-at-ASSP-Safety26-Expo Soleno Therapeutics Presents New VYKAT® XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period https://tradeshownews.vporoom.com/2026-06-15-Soleno-Therapeutics-Presents-New-VYKAT-R-XR-diazoxide-choline-Data-at-ENDO-2026-Demonstrating-Meaningful-and-Durable-Improvements-in-Hyperphagia-and-Behavioral-Symptoms-in-Prader-Willi-Syndrome-Following-Randomized-Withdrawal-Period Mon, 15 Jun 2026 16:10:00 -0400 https://tradeshownews.vporoom.com/2026-06-15-Soleno-Therapeutics-Presents-New-VYKAT-R-XR-diazoxide-choline-Data-at-ENDO-2026-Demonstrating-Meaningful-and-Durable-Improvements-in-Hyperphagia-and-Behavioral-Symptoms-in-Prader-Willi-Syndrome-Following-Randomized-Withdrawal-Period Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026 https://tradeshownews.vporoom.com/2026-06-15-Neurocrine-Biosciences-Presents-First-Retrospective-Case-Series-of-CRENESSITY-R-crinecerfont-in-Patients-with-Classic-Congenital-Adrenal-Hyperplasia-Due-to-11-Hydroxylase-Deficiency-at-ENDO-2026 Mon, 15 Jun 2026 16:05:00 -0400 https://tradeshownews.vporoom.com/2026-06-15-Neurocrine-Biosciences-Presents-First-Retrospective-Case-Series-of-CRENESSITY-R-crinecerfont-in-Patients-with-Classic-Congenital-Adrenal-Hyperplasia-Due-to-11-Hydroxylase-Deficiency-at-ENDO-2026